Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • SALIX PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: SLXP

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.000 Buy 9
    30 Days Ago 2.500 Hold 8
    60 Days Ago 2.500 Hold 8
    90 Days Ago 2.571 Hold 7
    120 Days Ago 2.333 Buy 6
  • Analyst Ratings: SLXP

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Wedbush Morgan Underperform Outperform 09/23/2009 25.00
    Merriman Buy 08/11/2009
    Piper Jaffray Overweight 07/07/2009 17.00
    Credit Suisse Neutral Outperform 06/15/2009
    Roth Capital Hold Buy 06/05/2009 12.50
    Caris & Company Buy 03/31/2009 16.00
    Wedbush Morgan Hold 03/26/2009
    Credit Suisse Neutral 03/20/2009 8.00
    Roth Capital Buy Hold 08/05/2008 8.00
    Roth Capital Buy 03/04/2008 8.25
    Credit Suisse Neutral 02/28/2008 7.00
    Friedman Billings Mkt Perform 02/08/2008
    Roth Capital Buy 02/01/2008 11.00
    Friedman Billings Mkt Perform 02/01/2008 7.50
    Roth Capital Buy 12/31/2007 13.50
    Piper Jaffray Neutral Sell 12/31/2007
    Friedman Billings Mkt Perform 12/31/2007 8.50
    Roth Capital Buy 09/06/2007 17.00
    Roth Capital Buy 05/09/2007 16.00
    Susquehanna Financial Neutral 10/19/2006
    Roth Capital Buy 07/20/2006 17.00
    BMO Nesbitt Burns Market Perform 07/11/2006 13.00
    William Blair Outperform Mkt Perform 02/27/2006
    Sun Trust Rbsn Humphrey Neutral Buy 06/06/2005 22.50
    Piper Jaffray Market Perform 01/21/2005 21.00
    Roth Capital Buy Strong Buy 01/06/2005 27.00
    Sun Trust Rbsn Humphrey Buy Neutral 11/18/2004
    Roth Capital Buy 08/10/2004 26.67
    Roth Capital Strong Buy Buy 07/02/2004 40.00
    CE Unterberg Towbin Market Perform Buy 06/17/2004 40.00